Andrew McDonald Biography and Net Worth

Andrew McDonald, PhD is a member of Vincerx’s board of directors. Dr McDonald has served as chief executive officer and as a member of the board of directors of LSAC since June 2019. Dr McDonald has served as chief executive officer of Attune Pharmaceuticals, a clinical-stage biotechnology company, since March 2015 and is a founding partner of LifeSci Advisors, LLC, a life sciences investor relations consultancy company, and LifeSci Capital, LLC, an emerging life sciences investment bank. Before founding LifeSci Advisors, LLC, and LifeSci Capital, LLC, in March 2010, Dr McDonald served as senior biotechnology analyst at Great Point Partners, a dedicated life science hedge fund, from 2006 to 2008. From 2004 to 2006, Dr McDonald served as head of healthcare research and a biotechnology analyst at ThinkEquity Partners, a boutique investment bank. Before entering the financial services industry, Dr McDonald was a medicinal chemist at Cytokinetics, Inc., a biopharmaceutical company, from 2001 to 2004, where he discovered and developed a promising anti-cancer agent now in clinical trials. Dr McDonald began his pharmaceutical career as a medicinal chemist at Pfizer. Dr McDonald received a PhD in organic chemistry from University of California, Irvine and completed his BS in chemistry at University of California, Berkeley. Dr McDonald holds Series 7, 24, 63, 79, 86, and 87 licenses.